Trial intelligence / Profile preview

18F-PSMA-1007 vs 18F-FDG PET/CT in Multiple Myeloma

NCT05448404Unknown

Sponsor
First Hospital of China Medical University
Start
Mar 2022
Primary completion
May 2023
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by First Hospital of China Medical University. Primary endpoint: number of myeloma lesions at 1 year. Status: unknown.

Beyond the preview

Go deeper on NCT05448404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05448404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call